Alzheimer's disease (AD) is a complex neurodegenerative disorder with cognitive
impairment and major neuropathologic hallmark of amyloid-beta (Aβ) peptides. Risperidone …

In this study, we investigated the effect of intracerebroventricular administration of ERK and
p38 specific inhibitors, U0126 and PD169316, respectively, on learning and memory deficits …

Reserpine, an anti-hypertensive drug, is able to positively modulate several phenotypes
associated with Aβ toxicity in a Caenorhabditis elegans model of Alzheimer's disease (AD) …

Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
extracellular amyloid plaques and intracellular neurofibrillary tangles. It is the most common …

A high co-morbidity between Alzheimer's disease (AD) and depression suggests there might
be similar mechanisms underlying the course of these diseases. Previous studies have …

Aggregation of amyloid β protein (A β) and progressive loss of memory are the main
characteristics of Alzheimer's disease (AD). It is noteworthy that approximately 40% of AD …

Background Alzheimer's disease (AD) is a complex and common neurodegenerative
disorder. The present study aimed to investigate the potential effects of selegiline (SEL) on …

Resveratrol, a natural polyphenol found in red wine, has wide spectrum of pharmacological
properties including antioxidative and antiaging activities. Beta amyloid peptides (Aβ) are …

Alzheimer's disease (AD) is a major global public health concern and social care problem
that is associated with learning, memory, and cognitive deficits. Riluzole is a glutamate …

Beta amyloid (Aβ)-induced oxidative stress and chronic inflammation in the brain are
considered to be responsible for the pathogenesis of Alzheimer's disease (AD). Salidroside …